308 related articles for article (PubMed ID: 8501155)
41. Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism.
Goodman WG; Veldhuis JD; Belin TR; Juppner H; Salusky IB
Kidney Int; 1997 May; 51(5):1590-5. PubMed ID: 9150477
[TBL] [Abstract][Full Text] [Related]
42. Regulation of parathyroid hormone and vitamin D in essential hypertension.
Young EW; Morris CD; Holcomb S; McMillan G; McCarron DA
Am J Hypertens; 1995 Oct; 8(10 Pt 1):957-64. PubMed ID: 8845076
[TBL] [Abstract][Full Text] [Related]
43. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
[TBL] [Abstract][Full Text] [Related]
44. Intact parathyroid hormone in primary hyperparathyroidism.
Flentje D; Schmidt-Gayk H; Fischer S; Stern J; Blind E; Buhr H; Herfarth C
Br J Surg; 1990 Feb; 77(2):168-72. PubMed ID: 2317677
[TBL] [Abstract][Full Text] [Related]
45. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
[TBL] [Abstract][Full Text] [Related]
46. Parathyroid function in mild to moderate renal failure: evaluation by oral calcium suppression test.
St John A; Thomas M; Dick I; Young P; Prince RL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1436-8. PubMed ID: 8200947
[TBL] [Abstract][Full Text] [Related]
47. Demonstration of a diurnal variation in serum parathyroid hormone in primary and secondary hyperparathyroidism.
Sinha TK; Miller S; Feming J; Khairi R; Edmondson J; Johnston CC; Bell NH
J Clin Endocrinol Metab; 1975 Dec; 41(06):1009-13. PubMed ID: 1239461
[TBL] [Abstract][Full Text] [Related]
48. Ionized calcium and the in vivo response of normal and hyperplastic parathyroid glands to beta-adrenergic agents.
McCarron DA; Muther RS; Plant SB; Krutzik S
Nephron; 1982; 32(2):149-54. PubMed ID: 7177292
[TBL] [Abstract][Full Text] [Related]
49. Normal responsiveness of serum parathyroid hormone to beta-adrenergic blockade in patients with secondary hyperparathyroidism.
Kukreja SC; Williams GA; Vora NM; Hargis GK
Horm Metab Res; 1981 Apr; 13(4):233-5. PubMed ID: 6113198
[TBL] [Abstract][Full Text] [Related]
50. Altered diurnal regulation of blood ionized calcium and serum parathyroid hormone concentrations during parenteral nutrition.
Goodman WG; Misra S; Veldhuis JD; Portale AA; Wang HJ; Ament ME; Salusky IB
Am J Clin Nutr; 2000 Feb; 71(2):560-8. PubMed ID: 10648272
[TBL] [Abstract][Full Text] [Related]
51. Carboxyl-terminal fragments of parathyroid hormone are not secreted preferentially in primary hyperparathyroidism as they are in other hypercalcemic conditions.
Brossard JH; Whittom S; Lepage R; D'Amour P
J Clin Endocrinol Metab; 1993 Aug; 77(2):413-9. PubMed ID: 8345045
[TBL] [Abstract][Full Text] [Related]
52. Dynamic tests of parathyroid hormone secretion using hemodialysis and calcium infusion cannot be compared.
Moysés RM; Pereira RC; Machado dos Reis L; Sabbaga E; Jorgetti V
Kidney Int; 1999 Aug; 56(2):659-65. PubMed ID: 10432406
[TBL] [Abstract][Full Text] [Related]
53. Pulse amplitude and frequency modulation of parathyroid hormone in primary hyperparathyroidism.
Harms HM; Schlinke E; Neubauer O; Kayser C; Wüstermann PR; Horn R; Külpmann WR; von zur Mühlen A; Hesch RD
J Clin Endocrinol Metab; 1994 Jan; 78(1):53-7. PubMed ID: 8288713
[TBL] [Abstract][Full Text] [Related]
54. Effects of minor increase in serum calcium on the immunoheterogeneity of parathyroid hormone in healthy subjects and in patients with primary hyperparathyroidism.
Ahrén B; Bergenfelz A
Horm Res; 1995; 43(6):294-9. PubMed ID: 7607615
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a standardized short-time calcium suppression test in healthy subjects: interest for the diagnosis of primary hyperparathyroidism.
Titon I; Cailleux-Bounacer A; Basuyau JP; Lefebvre H; Savouré A; Kuhn JM
Eur J Endocrinol; 2007 Sep; 157(3):351-7. PubMed ID: 17766719
[TBL] [Abstract][Full Text] [Related]
56. Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans.
Brent GA; LeBoff MS; Seely EW; Conlin PR; Brown EM
J Clin Endocrinol Metab; 1988 Nov; 67(5):944-50. PubMed ID: 3141451
[TBL] [Abstract][Full Text] [Related]
57. Calcium clamp technique: suppression of serum intact PTH by induced hypercalcaemia in normal man and primary hyperparathyroidism.
Sørensen HA; Schwarz P; McNair P; Hyldstrup L; Transbøl I
Scand J Clin Lab Invest; 1992 Oct; 52(6):457-65. PubMed ID: 1411258
[TBL] [Abstract][Full Text] [Related]
58. Influence of continuous infusion of citrate on responses of immunoreactive parathyroid hormone, calcium and magnesium components, and other electrolytes in normal adults during plateletapheresis.
Toffaletti J; Nissenson R; Endres D; McGarry E; Mogollon G
J Clin Endocrinol Metab; 1985 May; 60(5):874-9. PubMed ID: 3980672
[TBL] [Abstract][Full Text] [Related]
59. Aging alters calcium regulation of serum concentration of parathyroid hormone in healthy men.
Portale AA; Lonergan ET; Tanney DM; Halloran BP
Am J Physiol; 1997 Jan; 272(1 Pt 1):E139-46. PubMed ID: 9038863
[TBL] [Abstract][Full Text] [Related]
60. Inter-relations between the calcium set-points of Parfitt and Brown in primary hyperparathyroidism: a sequential citrate and calcium clamp study.
Schwarz P; Sørensen HA; Transbøl I
Eur J Clin Invest; 1994 Aug; 24(8):553-8. PubMed ID: 7982443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
